AGO-OVAR12 (BI 1199.15)

Trial Description: 
Multicenter, randomised, double-blind phase III trial to investigate the efficacy and safety of BIBF 1120 in combination with carboplatin and paclitaxel compared to placebo plus carboplatin and paclitaxel in patients with advanced ovarian cancer
Lead Cooperative Group: 
Disease Site: 
Ovarian
Trial Status: 
Completed
Contact person: